Top Markets
Coin of the day
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

PBAX
Rank in Stocks #15373
Phoenix Biotech Acquisition Corp. currently lacks substantial business... Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Share Price
$5.85
Last synced: 2024-02-14
Market Cap
$356.42M
Change (1 day)
4.65%
Change (1 year)
0.00%
Country
US
Trade Phoenix Biotech Acquisition Corp. (PBAX)
P/B ratio for Phoenix Biotech Acquisition Corp. (PBAX)
P/B ratio as of 2026 TTM: 0
According to Phoenix Biotech Acquisition Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Phoenix Biotech Acquisition Corp. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors